|
MBD5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.844000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.147800E-01 |
| Normal-vs-Stage2 |
3.181800E-01 |
| Normal-vs-Stage3 |
1.067900E-02 |
| Normal-vs-Stage4 |
1.040310E-03 |
| Stage1-vs-Stage2 |
3.824400E-01 |
| Stage1-vs-Stage3 |
1.080140E-02 |
| Stage1-vs-Stage4 |
5.012700E-04 |
| Stage2-vs-Stage3 |
3.292000E-01 |
| Stage2-vs-Stage4 |
9.686100E-02 |
| Stage3-vs-Stage4 |
4.038400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.364300E-02 |
| Normal-vs-AfricanAmerican |
4.982100E-02 |
| Normal-vs-Asian |
2.508400E-01 |
| Caucasian-vs-AfricanAmerican |
4.044600E-01 |
| Caucasian-vs-Asian |
1.854380E-01 |
| AfricanAmerican-vs-Asian |
8.288100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.581700E-03 |
| Normal-vs-Female |
9.938200E-01 |
| Male-vs-Female |
4.239900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.236410E-01 |
| Normal-vs-Age(41-60Yrs) |
5.743600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.570300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.340780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.813610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.107400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.182000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.177600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.630200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.343600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.902100E-02 |
| Normal-vs-Grade 2 |
9.384200E-01 |
| Normal-vs-Grade 3 |
2.398400E-02 |
| Normal-vs-Grade 4 |
6.21439999999307E-05 |
| Grade 1-vs-Grade 2 |
1.491430E-01 |
| Grade 1-vs-Grade 3 |
1.031640E-02 |
| Grade 1-vs-Grade 4 |
3.049800E-04 |
| Grade 2-vs-Grade 3 |
8.740300E-03 |
| Grade 2-vs-Grade 4 |
4.31510000000745E-05 |
| Grade 3-vs-Grade 4 |
1.547900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.095780E-01 |
| Normal-vs-ccB subtype |
1.720510E-03 |
| ccA subtype-vs-ccB subtype |
1.6561000004689E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.325000E-01 |
| Normal-vs-N1 |
2.780400E-01 |
| N0-vs-N1 |
5.157000E-01 |
|
|
